Gary J. Nabel

59.7k total citations · 13 hit papers
365 papers, 38.2k citations indexed

About

Gary J. Nabel is a scholar working on Immunology, Virology and Molecular Biology. According to data from OpenAlex, Gary J. Nabel has authored 365 papers receiving a total of 38.2k indexed citations (citations by other indexed papers that have themselves been cited), including 162 papers in Immunology, 130 papers in Virology and 114 papers in Molecular Biology. Recurrent topics in Gary J. Nabel's work include HIV Research and Treatment (130 papers), Immune Cell Function and Interaction (79 papers) and Virus-based gene therapy research (61 papers). Gary J. Nabel is often cited by papers focused on HIV Research and Treatment (130 papers), Immune Cell Function and Interaction (79 papers) and Virus-based gene therapy research (61 papers). Gary J. Nabel collaborates with scholars based in United States, France and United Kingdom. Gary J. Nabel's co-authors include David Baltimore, Zhi-Yong Yang, Elizabeth G. Nabel, Kwanyee Leung, Wing-Pui Kong, John R. Mascola, Ling Xu, Neil D. Perkins, Gregory E. Plautz and Peter D. Kwong and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Gary J. Nabel

361 papers receiving 36.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An inducible transcription factor activates expression of human immunodeficiency virus in T cells

1987 1.8k citations Gary J. Nabel et al. Nature profile →
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01

2010 821 citations Tongqing Zhou, Ivelin S. Georgiev et al. Science profile →
Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans.

1993 692 citations Gary J. Nabel et al. profile →
Regulation of NF-κB by Cyclin-Dependent Kinases Associated with the p300 Coactivator

1997 645 citations Neil D. Perkins, Kwanyee Leung et al. Science profile →
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies

2013 642 citations Masaru Kanekiyo, Chih‐Jen Wei et al. Nature profile →
HIV vaccine design and the neutralizing antibody problem

2004 610 citations Peter D. Kwong, Gary J. Nabel et al. profile →
Structural definition of a conserved neutralization epitope on HIV-1 gp120

2007 600 citations Tongqing Zhou, Ling Xu et al. Nature profile →
HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-κB-like factor

1988 550 citations Kwanyee Leung, Gary J. Nabel Nature profile →
Activation of HIV gene expression during monocyte differentiation by induction of NF-kB

1989 533 citations George E. Griffin, Kwanyee Leung et al. Nature profile →
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection

2015 515 citations Jeffrey C. Boyington, Patrick M. McTamney et al. profile →
Development of a preventive vaccine for Ebola virus infection in primates

2000 512 citations Nancy J. Sullivan, Zhi-Yong Yang et al. Nature profile →
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

2004 509 citations Zhi-Yong Yang, Wing-Pui Kong et al. Nature profile →
Next-generation influenza vaccines: opportunities and challenges

2020 234 citations Chih‐Jen Wei, Michelle C. Crank et al. profile →

Peers

Countries citing papers authored by Gary J. Nabel

Since Specialization

Citations

This map shows the geographic impact of Gary J. Nabel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary J. Nabel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary J. Nabel more than expected).

Fields of papers citing papers by Gary J. Nabel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary J. Nabel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary J. Nabel. The network helps show where Gary J. Nabel may publish in the future.

Co-authorship network of co-authors of Gary J. Nabel

This figure shows the co-authorship network connecting the top 25 collaborators of Gary J. Nabel. A scholar is included among the top collaborators of Gary J. Nabel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary J. Nabel. Gary J. Nabel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350 2025 ·Immunity ·(unknown), Wei Bu, Wei‐Hung Chen, Rebecca A. Gillespie, Sarah F. Andrews, Adam K. Wheatley, Yaroslav Tsybovsky, (unknown), Tyler Stephens, Madhu Prabhakaran, Brian E. Fisher, Sandeep Narpala, (unknown), Adrian B. McDermott, Gary J. Nabel, Peter D. Kwong, John R. Mascola, Jeffrey I. Cohen, Masaru Kanekiyo	3
2	A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates 2022 ·Science Translational Medicine ·Ruth Hunegnaw, Anna N. Honko, Lingshu Wang, (unknown), (unknown), Wei Shi, Lam Nguyen, Nadia Storm, Caitlyn N M Dulan, Kathryn E. Foulds, Krystle N. Agans, Robert W. Cross, Joan B. Geisbert, Cheng Cheng, Aurélie Ploquin, Daphne A. Stanley, Thomas W. Geisbert, Gary J. Nabel, Nancy J. Sullivan	25
3	A bivalent Epstein-Barr virus vaccine induces neutralizing antibodies that block infection and confer immunity in humanized mice 2022 ·Science Translational Medicine ·Chih‐Jen Wei, Wei Bu, Laura A. Nguyen, Joseph D. Batchelor, (unknown), Stefania Pittaluga, James R. Fuller, Hanh Nguyen, Te-Hui Chou, Jeffrey I. Cohen, Gary J. Nabel	64
4	Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates 2021 ·Science Translational Medicine ·Nicole Darricarrère, Yu Qiu, Masaru Kanekiyo, Adrian Creanga, Rebecca A. Gillespie, Syed M. Moin, Jacqueline Saleh, José Sancho, Te-Hui Chou, (unknown), Ruijun Zhang, Shujia Dai, M. Anthony Moody, Kevin O. Saunders, Michelle C. Crank, John R. Mascola, Barney S. Graham, Chih‐Jen Wei, Gary J. Nabel	46
5	A respiratory syncytial virus (RSV) F protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domain 2020 ·Science Immunology ·Kurt A. Swanson, (unknown), (unknown), (unknown), (unknown), Michael Kishko, Vincent Pavot, (unknown), Haritha Adhikarla, (unknown), Sudha Chivukula, Scott Gallichan, Linong Zhang, Nicholas Jackson, Heesik Yoon, Darin Edwards, Chih‐Jen Wei, Gary J. Nabel	83
6	Report of the Cent Gardes HIV Vaccines Conference. Part 1: The antibody response; Fondation Mérieux Conference Center, Veyrier-du-Lac, France, 25–27 October 2015 2016 ·Vaccine ·Marc Girard, R. Legrand, Valentina Picot, Christophe Longuet, Gary J. Nabel	1
7	Report of the 2014 Cent Gardes HIV Vaccine Conference – Part 1: Neutralizing Antibodies; Fondation Mérieux Conference Center, Veyrier du Lac, France, 5–7 October 2014 2015 ·Vaccine ·Marc Girard, Valentina Picot, Christophe Longuet, Gary J. Nabel	1
8	Distinct Evolutionary Pressures Underlie Diversity in Simian Immunodeficiency Virus and Human Immunodeficiency Virus Lineages 2012 ·Journal of Virology ·Will Fischer, Cristian Apetrei, Mario L. Santiago, Yingying Li, Rajeev Gautam, Ivona Pandrea, George M. Shaw, Beatrice H. Hahn, Norman L. Letvin, Gary J. Nabel, Bette Korber	21
9	HIV : from biology to prevention and treatment : a subject collection from Cold Spring Harbor perspectives in medicine 2012 ·Frederic D. Bushman, Gary J. Nabel, (unknown)	1
10	Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 breakdown → 2010 ·Science ·Tongqing Zhou, Ivelin S. Georgiev, Xueling Wu, Zhi-Yong Yang, Kaifan Dai, Andrés Finzi, Young Do Kwon, Johannes F. Scheid, Wei Shi, Ling Xu, Yongping Yang, Jiang Zhu, Michel C. Nussenzweig, Joseph Sodroski, Lawrence Shapiro, Gary J. Nabel, John R. Mascola, Peter D. Kwong	821
11	Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination 2010 ·Science ·Chih‐Jen Wei, Jeffrey C. Boyington, Patrick M. McTamney, Wing-Pui Kong, Melissa B. Pearce, Ling Xu, Hanné Andersen, Srinivas S. Rao, Terrence M. Tumpey, Zhi-Yong Yang, Gary J. Nabel	277
12	Systemic and Mucosal T-Lymphocyte Activation Induced by Recombinant Adenovirus Vaccines in Rhesus Monkeys 2009 ·Journal of Virology ·Yue Sun, Robert T. Bailer, Srinivas S. Rao, John R. Mascola, Gary J. Nabel, Richard A. Koup, Norman L. Letvin	14
13	Expanded Breadth of the T-Cell Response to Mosaic Human Immunodeficiency Virus Type 1 Envelope DNA Vaccination 2008 ·Journal of Virology ·Wing-Pui Kong, Lan Wu, Timothy C. Wallstrom, Will Fischer, Zhi-Yong Yang, Sung‐Youl Ko, Norman L. Letvin, Barton F. Haynes, Beatrice H. Hahn, Bette Korber, Gary J. Nabel	54
14	Preserved CD4+ Central Memory T Cells and Survival in Vaccinated SIV-Challenged Monkeys 2006 ·Science ·Norman L. Letvin, John R. Mascola, Yue Sun, Darci A. Gorgone, Adam P. Buzby, Ling Xu, Zhi-Yong Yang, Bimal K. Chakrabarti, Srinivas S. Rao, Jörn E. Schmitz, David C. Montefiori, Brianne R. Barker, Fred L. Bookstein, Gary J. Nabel	287
15	How much longer will tumour cells fool the immune system? 2000 ·Immunology Today ·Soldano Ferrone, John F. Finerty, Elizabeth M. Jaffee, Gary J. Nabel	34
16	Transcriptional Regulation of NF-κB2: Evidence for κB-Mediated Positive and Negative Autoregulation 1994 ·Molecular and Cellular Biology ·Susanne Liptay, Roland M. Schmid, Elizabeth G. Nabel, Gary J. Nabel	98
17	Gene therapy approaches to AIDS 1994 ·AIDS ·Gary J. Nabel	7
18	Dimerization of NF-KB2 with RelA(p65) Regulates DNA Binding, Transcriptional Activation, and Inhibition by an IκB-α (MAD-3) 1993 ·Molecular and Cellular Biology ·Colin S. Duckett, Neil D. Perkins, Timothy F. Kowalik, Roland M. Schmid, Eng‐Shang Huang, Albert S. Baldwin, Gary J. Nabel	43
19	cis -Acting Sequences Required for Inducible Interleukin-2 Enhancer Function Bind a Novel Ets-Related Protein, Elf-1 1992 ·Molecular and Cellular Biology ·Craig B. Thompson, (unknown), I‐Cheng Ho, Paul R. Bohjanen, Bronislawa Petryniak, Carl H. June, Susan Miesfeldt, (unknown), Gary J. Nabel, Beverly A. Karpinski, Jeffrey M. Leiden	66
20	NF-κB and HIV (I: Reply) 1990 ·Nature ·George E. Griffin, Kwanyee Leung, T M Folks, S L Kunkel, Gary J. Nabel	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact